William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, discusses the benefits ...
Survival analysis of pyrotinib in HER2-positive metastatic breast cancer: A multicenter real-world study. A randomized, double-blind, three-arm, parallel group, phase 1 study to assess the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results